Hematopoiesis News Volume 6.36 | Sep 15 2015

Overexpression and Knockout of miR-126 Both Promote Leukemogenesis through Targeting Distinct Gene Signaling
Researchers showed that both overexpression and knockout of miR-126 result in enhanced leukemogenesis in cooperation with t(8;21) fusion genes, AML1-ETO/RUNX1-RUNX1T1 or AML1-ETO9a. [Blood] Abstract

The Phosphatases STS1 and STS2 Regulate Hematopoietic Stem and Progenitor Cell Fitness
Scientists investigated the role of STS1 and STS2 on FLT3 and c-KIT phosphorylation, activity, and function in normal and stress-induced hematopoiesis. [Stem Cell Reports] Full Article | Graphical Abstract

GATA2 Regulates Wnt Signaling to Promote Primitive Red Blood Cell Fate
Investigators showed that up-regulation of canonical Wnt signaling during gastrulation blocks commitment to a hematopoietic fate while down-regulation of non-canonical Wnt signaling impairs erythroid differentiation. [Dev Biol] Abstract

FANCA Safeguards Interphase and Mitosis during Hematopoiesis In Vivo
Scientists quantified the origins of genomic instability in Fanconi anemia (FA) patients and mice in vivo and ex vivo. They found that both mitotic errors and interphase DNA damage significantly contribute to genomic instability during FA-deficient hematopoiesis and in non-hematopoietic human and murine FA primary cells. [Exp Hematol] Abstract | Full Article

Follistatin-Like 1 Attenuates Differentiation and Survival of Erythroid Cells through Smad2/3 Signaling
Scientists report that follistatin-like 1 (FSTL1) treatment impairs hemin-induced erythroid differentiation and cell survival. FSTL1 differentially regulated transforming growth factor beta and bone morphogenetic protein signaling. [Biochem Biophys Res Commun] Full Article

CLINICAL RESEARCH

Efficacy and Safety of Deferasirox in Non-Thalassemic Patients with Elevated Ferritin Levels after Allogeneic Hematopoietic Stem Cell Transplantation
A multicenter DE02 trial assessed the safety, efficacy and impact of deferasirox on iron homeostasis after allogeneic hematopoietic stem cell transplantation. [Bone Marrow Transplant] Abstract

UGT2B17 Minor Histocompatibility Mismatch and Clinical Outcome after HLA-Identical Sibling Donor Stem Cell Transplantation
The authors retrospectively studied the clinical impact of a UGT2B17 mismatch in a cohort of 1127 patients receiving a hematopoietic stem cell transplantation from an HLA-identical sibling donor. [Bone Marrow Transplant] Abstract

Visit our reviews page to see a complete list of reviews in the hematopoiesis research field.

Avillion Announces Completion of Enrolment in Phase III BFORE Trial to Assess BOSULIF^® (Bosutinib) as First-Line Treatment for Patients with Chronic Myelogenous Leukemia
Avillion LLP announced the completion of enrollment in a global Phase III clinical trial called “BFORE,” which is designed to assess the effectiveness and safety of BOSULIF^® (bosutinib) as a first-line treatment for patients with chronic phase Philadelphia chromosome positive chronic myelogenous leukemia. [Avillion LLP (PR Newswire Association LLC.)] Press Release

From our sponsor: Working with blood? Request your free wallchart on human blood cell frequencies.

Food and Drug Administration (United States)

Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)

Visit our events page to see a complete list of events in the hematopoiesis community.

Principal Scientist – Hematopoietic Products (STEMCELL Technologies Inc.)

Director of Research – Oncology and Hematology (CancerCare Manitoba)

Postdoctoral Fellow – HMGA Chromatin Remodeling Proteins in Cancer and Stem Cell Biology (Johns Hopkins University School of Medicine)

Regulatory Coordinator – Leukemia (Fred Hutchinson Cancer Research Center)

Postdoctoral Position – Hematologic Malignancies (Northwestern University)

Postdoctoral Research Associate – Pharmacogenomics (St. Jude Children’s Research Hospital)

Postdoctoral Fellow – Hematopoietic Regeneration and Myeloid Malignancies (Weill-Cornell Medical College)

Postdoctoral Position – Hematopoietic Stem and Progenitor Cell Assays (Weill Cornell Medical School)

Research Associate – Cell Biology (Editas Medicine)

Clinical Research Coordinator – Chronic Lymphocytic Leukemia (Fred Hutchinson Cancer Research Center)

Recruit Top Talent: Reach more than 60,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.